Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection

Journal of Clinical Investigation

Volumn 126, Issue 4, 2016, Pages 1566-1580

  Peteranderl, Christin ^a,b   Morales Nebreda, Luisa ^b   Selvakumar, Balachandar ^a,b   Lecuona, Emilia ^b   Vadász, István ^a,b   Morty, Rory E ^a,b,c   Schmoldt, Carole ^a,b   Bespalowa, Julia ^a,b   Wolff, Thorsten ^d   Pleschka, Stephan ^e   Mayer, Konstantin ^a,b   Gattenloehner, Stefan ^e   Fink, Ludger ^b,f   Lohmeyer, Juergen ^a,b   Seeger, Werner ^a,b,c   Sznajder, Jacob I ^b   Mutlu, Gökhan M ^g   Budinger, G R Scott ^b   Herold, Susanne ^a,b  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b NORTHWESTERN UNIVERSITY   (United States)

^c MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^d ROBERT KOCH INSTITUTE   (Germany)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

^f Institute of Pathology and Cytology   (Germany)

^g UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); INTERFERON; SALBUTAMOL; TNFSF10 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ARTICLE; CELL COMMUNICATION; CELL MEMBRANE; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; INFLUENZA A (H1N1); LUNG ALVEOLUS EPITHELIUM CELL; LUNG ALVEOLUS MACROPHAGE; LUNG CLEARANCE; LUNG EDEMA; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; IMMUNOLOGY; INFLUENZA A VIRUS; LUNG ALVEOLUS; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; RESPIRATORY MUCOSA;

ANIMALS; HUMANS; INFLUENZA A VIRUS; INTERFERON TYPE I; MACROPHAGES, ALVEOLAR; MICE; ORTHOMYXOVIRIDAE INFECTIONS; PARACRINE COMMUNICATION; PULMONARY ALVEOLI; PULMONARY EDEMA; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY MUCOSA; SODIUM-POTASSIUM-EXCHANGING ATPASE; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84964662661     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI83931     Document Type: Article

References (70)

1. Jain S, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009;361(20):1935-1944.
2. Short KR, Kroeze EJ, Fouchier RA, Kuiken T. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis. 2014;14(1):57-69.
3. Kuiken T, Taubenberger JK. Pathology of human influenza revisited. Vaccine. 2008;26(suppl 4):D59-D66.
4. Herold S, et al. Lung epithelial apoptosis in influenza virus pneumonia: The role of macrophageexpressed TNF-related apoptosis-inducing ligand. J Exp Med. 2008;205(13):3065-3077.
5. Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest. 2012;122(8):2731-2740.
6. Sznajder JI. Alveolar edema must be cleared for the acute respiratory distress syndrome patient to survive. Am J Respir Crit Care Med. 2001;163(6):1293-1294.
7. Matthay MA. Alveolar fluid clearance in patients with ARDS: does it make a difference? Chest. 2002;122(6 suppl):340S-343S.
8. Folkesson HG, Matthay MA. Alveolar epithelial ion and fluid transport: recent progress. Am J Respir Cell Mol Biol. 2006;35(1):10-19.
9. Borok Z, Verkman AS. Lung edema clearance: 20 years of progress: invited review: role of aquaporin water channels in fluid transport in lung and airways. J Appl Physiol. 2002;93(6):2199-2206.
10. Machado-Aranda D, et al. Gene transfer of the Na+,K+-ATPase β1 subunit using electroporation increases lung liquid clearance. Am J Respir Crit Care Med. 2005;171(3):204-211.
11. Adir Y, et al. Overexpression of the Na-K-ATPase α2-subunit improves lung liquid clearance during ventilation-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 2008;294(6):L1233-L1237.
12. Lecuona E, Trejo HE, Sznajder JI. Regulation of Na,K-ATPase during acute lung injury. J Bioenerg Biomembr. 2007;39(5-6):391-395.
13. Mutlu GM, Sznajder JI. Mechanisms of pulmonary edema clearance. Am J Physiol Lung Cell Mol Physiol. 2005;289(5):L685-L695.
14. Bertorello AM, et al. Analysis of Na+,K+-ATPase motion and incorporation into the plasma membrane in response to G proteincoupled receptor signals in living cells. Mol Biol. 2003;14(3):1149-1157.
15. Saldías FJ, et al. β-Adrenergic stimulation restores rat lung ability to clear edema in ventilatorassociated lung injury. Am J Respir Crit Care Med. 2000;162(1):282-287.
16. Högner K, et al. Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog. 2013;9(2):e1003188.
17. Wolk KE, et al. Influenza A virus inhibits alveolar fluid clearance in BALB/c mice. Am J Respir Crit Care Med. 2008;178(9):969-976.
18. Baskin CR, et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A. 2009;106(9):3455-3460.
19. De Jong MD, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006;12(10):1203-1207.
20. Bertorello AM, Ridge KM, Chibalin AV. Katz AI, Sznajder JI. Isoproterenol increases Na+-K+-ATPase activity by membrane insertion of α-subunits in lung alveolar cells. Am J Physiol. 1999;276(1):L20-L27.
21. Lecuona E, Sun H, Vohwinkel C, Ciechanover A, Sznajder JI. Ubiquitination participates in the lysosomal degradation of Na,K-ATPase in steady-state conditions. Am J Respir Cell Mol Biol. 2009;41(6):671-679.
22. Factor P, et al. Augmentation of lung liquid clearance via adenovirus-mediated transfer of a Na,K-ATPase β1 subunit gene. J Clin Invest. 1998;102(7):1421-1430.
23. Factor P, et al. Overexpression of the Na+,K+-ATPase α1 subunit increases Na+,K+-ATPase function in A549 cells. Am J Respir Cell Mol Biol. 1998;18(6):741-749.
24. Mutlu GM, et al. Upregulation of alveolar epithelial active Na+ transport is dependent on β2-adrenergic receptor signaling. Circ Res. 2004;94(8):1091-1100.
25. Barut S, et al. The neuroprotective effects of z-DEVD.fmk, a caspase-3 inhibitor, on traumatic spinal cord injury in rats. Surg Neurol. 2005;64(3):213-220.
26. Knoblach SM, et al. Caspase inhibitor z-DEVD-fmk attenuates calpain and necrotic cell death in vitro and after traumatic brain injury. J Cereb Blood Flow Metab. 2004;24(10):1119-1132.
27. Gusarova G, a et al. Hypoxia leads to Na,K-ATPase downregulation via Ca(2+) release-activated Ca(2+) channels and AMPK activation. Mol Cell Biol. 2011;31(17):3546-3556.
28. Vadász I, et al. AMP-activated protein kinase regulates CO2-induced alveolar epithelial dysfunction in rats and human cells by promoting Na,K-ATPase endocytosis. J Clin Invest. 2008;118(2):752-762.
29. Park SH, et al. Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. J Appl Physiol. 2002;92(6):2475-2482.
30. Kaushik VK, et al. Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR. Am J Physiol Endocrinol Metab. 2001;281(2):E335-E340.
31. Sullivan JE, et al. Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett. 1994;353(1):33-36.
32. Zhou G, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108(8):1167-1174.
33. Witczak CA, Sharoff CG, Goodyear LJ. AMPactivated protein kinase in skeletal muscle: from structure and localization to its role as a master regulator of cellular metabolism. Cell Mol Life Sci. 2008;65(23):3737-3755.
34. Ninomiya-Tsuji J, et al. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J Biol Chem. 2003;278(20):18485-18490.
35. Herold S, et al. Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules. J Immunol. 2006;177(3):1817.
36. Lazrak A, et al. Influenza virus M2 protein inhibits epithelial sodium channels by increasing reactive oxygen species. FASEB J. 2009;23(11):3829-3842.
37. Londino JD, et al. Influenza matrix protein 2 alters CFTR expression and function through its ion channel activity. Am J Physiol Lung Cell Mol Physiol. 2013;304(9):L582-L592.
38. Jewell NA, et al. Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J Virol. 2007;81(18):9790-9800.
39. Hayden FG, et al. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest. 1998;101(3):643-649.
40. Arimori Y, et al. Type I interferon limits influenza virus-induced acute lung injury by regulation of excessive inflammation in mice. Antiviral Res. 2013;99(3):230-237.
41. Steel J, et al. Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. J Virol. 2010;84(1):21-26.
42. Kugel D, et al. Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets. J Virol. 2009;83(8):3843-3851.
43. Tumpey TM, et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol. 2005;79(23):14933-14944.
44. Lin KL, Suzuki Y, Nakano H, Ramsburg E, Gunn MD. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol. 2008;180(4):2562-2572.
45. Chan M et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res. 2005;6(135):1-13.
46. Herold S, Becker C, Ridge KM, Budinger GRS. Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur Respir J. 2015;45(5):1463-1478.
47. Kim HM, et al. Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs. J Virol. 2008;82(9):4265-4274.
48. Walsh KB, et al. Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc Natl Acad Sci U S A. 2011;108(29):12018-12023.
49. Van Reeth K. Cytokines in the pathogenesis of influenza. Vet Microbiol. 2000;74(1-2):109-116.
50. Szretter KJ, et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol. 2007;81(6):2736-2744.
51. To KK, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis. 2010;50(6):850-859.
52. Davidson S, Crotta S, McCabe TM, Wack A. Pathogenic potential of interferon αβ in acute influenza infection. Nat Commun. 2014;5:3864.
53. Baritaki S, et al. Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. J Immunol. 2007;179(8):5441-5453.
54. Song K, Benhaga N, Anderson RL, Khosravi-Far R. Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo. Cancer Res. 2006;66(12):6304-6311.
55. Liu C, Liang B, Wang Q, Wu J, Zou MH. Activation of AMP-activated protein kinase alpha1 alleviates endothelial cell apoptosis by increasing the expression of anti-apoptotic proteins Bcl-2 and survivin. J Biol Chem. 2010;285(20):15346-15355.
56. Hardie DG, Scott JW, Pan DA, Hudson ER. Management of cellular energy by the AMPactivated protein kinase system. FEBS Lett. 2003;546(1):113-120.
57. Herrero-Martín G, et al. TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells. EMBO J. 2009;28(6):677-685.
58. Moseley CE, Webster RG, Aldridge JR. Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice. Influenza Other Respi. 2010;4(5):307-311.
59. Hoffmann HH, Palese P, Shaw ML. Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity. Antiviral Res. 2008;80(2):124-134.
60. Wang L, et al. "Tuning" of type I interferoninduced Jak-STAT1 signaling by calciumdependent kinases in macrophages. Nat Immunol. 2008;9(2):186-193.
61. Ellis GT, Davidson S, Crotta S, Branzk N, Papayannopoulos V, Wack A. TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfection. EMBO Rep. 2015;16(9):1203-1218.
62. Cretney E, et al. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J Immunol. 2002;168(3):1356-1361.
63. Müller U, et al. Functional role of type I and type II interferons in antiviral defense. Science. 1994;264(5167):1918-21.
64. Finnberg N, et al. DR5 knockout mice are compromised in radiation-induced apoptosis. Mol Cell Biol. 2005;25(5):2000-2013.
65. Kuziel WA, et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A. 1997;94(22):12053-12058.
66. Cakarova L, et al. Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair. Am J Respir Crit Care Med. 2009;180(6):521-532.
67. Barwe SP, et al. Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Mol Biol. 2005;16(3):1082-1094.
68. Hardiman KM, Lindsey JR, Matalon S. Lack of amiloride-sensitive transport across alveolar and respiratory epithelium of iNOS(-/-) mice in vivo. Am J Physiol Lung Cell Mol Physiol. 2001;281(3):L722-731.
69. Dada LA, et al. Hypoxia-induced endocytosis of Na,K-ATPase in alveolar epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-ζ. J Clin Invest. 2003;111(7):1057-1064.
70. Unkel B, et al. Alveolar epithelial cells orchestrate DC function in murine viral pneumonia. J Clin Invest. 2012;122(10):3652-3664.